Conference
ENESTCMR 4-Y RESULTS: PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) AND RESIDUAL DISEASE MORE LIKELY TO ACHIEVE DEEP MOLECULAR RESPONSE FOLLOWING SWITCH TO NILOTINIB (NIL)
Authors
Hughes TP; Cervantes F; Leber B; Spector N; Lipton JH; Pasquini R; Clementino NCD; Schwarer AP; Mahon FX; Rea D
Volume
100
Pagination
pp. 61-62
Publisher
FERRATA STORTI FOUNDATION
Publication Date
June 1, 2015
Name of conference
20th Congress of European-Hematology-Association
Conference place
Vienna, AUSTRIA
Conference start date
June 11, 2015
Conference end date
June 14, 2015
Conference proceedings
HAEMATOLOGICA
ISSN
0390-6078